buspirone has been researched along with Pervasive Child Development Disorders in 3 studies
Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We evaluated the efficacy and safety of buspirone in the management of anxiety and irritability in children with pervasive developmental disorders (PDD)." | 9.08 | Buspirone in the management of anxiety and irritability in children with pervasive developmental disorders: results of an open-label study. ( Buitelaar, JK; van der Gaag, RJ; van der Hoeven, J, 1998) |
| "We evaluated the efficacy and safety of buspirone in the management of anxiety and irritability in children with pervasive developmental disorders (PDD)." | 5.08 | Buspirone in the management of anxiety and irritability in children with pervasive developmental disorders: results of an open-label study. ( Buitelaar, JK; van der Gaag, RJ; van der Hoeven, J, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Orsagh-Yentis, DK | 1 |
| Wink, LK | 1 |
| Stigler, KA | 1 |
| Erickson, CA | 1 |
| McDougle, CJ | 1 |
| Buitelaar, JK | 1 |
| van der Gaag, RJ | 1 |
| van der Hoeven, J | 1 |
| Hollander, E | 1 |
| Dolgoff-Kaspar, R | 1 |
| Cartwright, C | 1 |
| Rawitt, R | 1 |
| Novotny, S | 1 |
2 trials available for buspirone and Pervasive Child Development Disorders
| Article | Year |
|---|---|
Buspirone in the management of anxiety and irritability in children with pervasive developmental disorders: results of an open-label study.
Topics: Adolescent; Anxiety; Buspirone; Child; Child Development Disorders, Pervasive; Female; Humans; Irrit | 1998 |
An open trial of divalproex sodium in autism spectrum disorders.
Topics: Adolescent; Adult; Age Factors; Anticonvulsants; Antipsychotic Agents; Asperger Syndrome; Autistic D | 2001 |
1 other study available for buspirone and Pervasive Child Development Disorders
| Article | Year |
|---|---|
Buspirone for bruxism in a child with pervasive developmental disorder-not otherwise specified.
Topics: Anti-Anxiety Agents; Bruxism; Buspirone; Child; Child Development Disorders, Pervasive; Humans; Male | 2011 |